SARS Cov 2 Vaccination in Adolescents With Juvenile Idiopathic Arthritis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

SARS Cov 2 Vaccination in Adolescents With Juvenile Idiopathic Arthritis — Stella

Home/SARS Cov 2 Vaccination in Adolescents With Juvenile Idiopathic Arthritis/

View on ClinicalTrials.gov

Recruiting

Back to SARS Cov 2 Vaccination in Adolescents With Juvenile Idiopathic Arthritis trials

Trial locations(1 site)

France

CHU de Nantes, Nantes, Loire-Atlantique

Key details

Sponsor

Nantes University Hospital

Collaborators

University Hospital, Angers, Rennes University Hospital

Enrollment target

~200 participants

Started

June 2024

Primary completion

June 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

12 Years – 18 Years

Last updated June 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.